|
Name |
12-O-deacetyl-phomoxanthone A
|
Molecular Formula | C36H36O15 | |
IUPAC Name* |
[4-acetyloxy-5-[5-acetyloxy-1,8-dihydroxy-10a-(hydroxymethyl)-6-methyl-9-oxo-6,7-dihydro-5H-xanthen-4-yl]-1,8-dihydroxy-3-methyl-9-oxo-3,4-dihydro-2H-xanthen-4a-yl]methylacetate
|
|
SMILES |
CC(=O)OCC12Oc3c(-c4ccc(O)c5c4OC4(CO)C(=C(O)CC(C)C4OC(C)=O)C5=O)ccc(O)c3C(=O)C1=C(O)CC(C)C2OC(C)=O
|
|
InChI |
InChI=1S/C36H36O15/c1-14-10-23(43)27-29(45)25-21(41)8-6-19(31(25)50-35(27,12-37)33(14)48-17(4)39)20-7-9-22(42)26-30(46)28-24(44)11-15(2)34(49-18(5)40)36(28,51-32(20)26)13-47-16(3)38/h6-9,14-15,33-34,37,41-44H,10-13H2,1-5H3/t14-,15-,33-,34-,35+,36+/m0/s1
|
|
InChIKey |
UYIWWMWDQWLQHT-PGQKKIPJSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 708.67 | ALogp: | 3.5 |
HBD: | 5 | HBA: | 15 |
Rotatable Bonds: | 6 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 232.6 | Aromatic Rings: | 6 |
Heavy Atoms: | 51 | QED Weighted: | 0.209 |
Caco-2 Permeability: | -5.273 | MDCK Permeability: | 0.00002090 |
Pgp-inhibitor: | 0.896 | Pgp-substrate: | 0.943 |
Human Intestinal Absorption (HIA): | 0.743 | 20% Bioavailability (F20%): | 0.07 |
30% Bioavailability (F30%): | 0.237 |
Blood-Brain-Barrier Penetration (BBB): | 0.005 | Plasma Protein Binding (PPB): | 84.17% |
Volume Distribution (VD): | 0.402 | Fu: | 15.97% |
CYP1A2-inhibitor: | 0.023 | CYP1A2-substrate: | 0.056 |
CYP2C19-inhibitor: | 0.025 | CYP2C19-substrate: | 0.061 |
CYP2C9-inhibitor: | 0.095 | CYP2C9-substrate: | 0.235 |
CYP2D6-inhibitor: | 0.105 | CYP2D6-substrate: | 0.093 |
CYP3A4-inhibitor: | 0.63 | CYP3A4-substrate: | 0.262 |
Clearance (CL): | 1.064 | Half-life (T1/2): | 0.034 |
hERG Blockers: | 0.019 | Human Hepatotoxicity (H-HT): | 0.94 |
Drug-inuced Liver Injury (DILI): | 0.968 | AMES Toxicity: | 0.018 |
Rat Oral Acute Toxicity: | 0.998 | Maximum Recommended Daily Dose: | 0.601 |
Skin Sensitization: | 0.023 | Carcinogencity: | 0.022 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.008 |
Respiratory Toxicity: | 0.041 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005075 | 0.881 | D0T5XN | 0.268 | ||||
ENC002978 | 0.816 | D07IPB | 0.266 | ||||
ENC005073 | 0.750 | D0Q0PR | 0.266 | ||||
ENC002870 | 0.736 | D08FPM | 0.264 | ||||
ENC001968 | 0.721 | D07VLY | 0.258 | ||||
ENC004764 | 0.701 | D0C9XJ | 0.258 | ||||
ENC001973 | 0.663 | D0N1FS | 0.256 | ||||
ENC001969 | 0.651 | D01XDL | 0.255 | ||||
ENC005069 | 0.631 | D01XWG | 0.255 | ||||
ENC002105 | 0.587 | D0FX2Q | 0.255 |